| abstract |
A pharmaceutical modified-release composition comprises lercanidipine dissolved in a waxy substance comprising a polyalcoholic fatty acid ester, the solution contained in a pharmaceutically acceptable capsule. Preferably, the polyalcoholic fatty acid ester is an ester of macrogol, an ester of polypropylene glycol, a glyceride of fatty acids or a mixture of two or more thereof. More preferably, the polyalcoholic fatty acid ester is a mixture of mono-, di- and triglycerides with mono- and diesters of the macrogol. |